Target intelligence / Profile preview

Zinc finger DHHC-type palmitoyltransferase 15 (ZDHHC15)

Target
ZDHHC15
Molecular classification
Enzyme (palmitoyltransferase; protein acyltransferase), Zinc finger protein, DHHC domain-containing protein
01

Overview

Zinc finger DHHC-type palmitoyltransferase 15 (ZDHHC15) is a protein-coding enzyme that catalyzes the addition of fatty acids (mainly palmitate, but also myristate and stearate) to substrate proteins, regulating processes such as protein trafficking and synaptic function. Containing a DHHC (Asp-His-His-Cys) palmitoyltransferase domain and a zinc finger, ZDHHC15 localizes to intracellular membranes, especially affecting endosomal and Golgi trafficking, and is highly expressed in nervous tissue where it modulates key synaptic proteins like DLG4/PSD95. Mutations or loss of ZDHHC15 are strongly linked to X-linked intellectual developmental disorder (MRX91), and roles in neurological development, glioma progression, and autism spectrum disorders have been described. Alternative splicing produces different isoforms with tissue-specific expression; substrate diversity gives rise to complex functional consequences when the enzyme is disrupted.

Other names
ZDHHC palmitoyltransferase 15DHHC-15MRX91Mental retardation, X-linked 91Acyltransferase ZDHHC15Zinc finger DHHC domain-containing protein 15Zinc finger, DHHC domain containing 15
02

Mechanism of action

As an enzyme, drugs targeting ZDHHC15 would most likely inhibit its palmitoyltransferase activity, blocking the transfer of fatty acids to protein substrates. Inhibition would thus alter substrate trafficking, localization, and stability, impacting synaptic function and potentially neurodevelopmental disease processes.

03

Biological functions

Protein palmitoylation (transfers fatty acids to substrate proteins)Regulation of protein trafficking (notably in endosomal–Golgi transport)Synaptic organization and clustering (via palmitoylation of DLG4/PSD95, impacting synaptogenesis in the nervous system)
04

Disease associations

Intellectual developmental disorder, X-linked 91 (MRX91)Fragile X syndromeAutism spectrum disorderGlioma
05

Safety considerations

Central nervous system effects: Targeting ZDHHC15 could disrupt normal synaptic organization, leading to neurodevelopmental or neuropsychiatric side effectsPotential broad substrate effects: Multiple proteins are palmitoylated by ZDHHC15; off-target effects in other tissues may pose a challenge for selective pharmacological modulation
06

Biomarkers

ZDHHC15 expression status (biomarker for glioma prognosis)Gene mutations or transcript loss used in intellectual disability diagnostics

Beyond the preview

Go deeper on Zinc finger DHHC-type palmitoyltransferase 15 (ZDHHC15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger DHHC-type palmitoyltransferase 15 (ZDHHC15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call